New antibiotics: NHS will test “pay for usefulness” model to stimulate research
The NHS will pay drug companies up front for access to new drugs depending on their usefulness, in an effort to encourage them to invest the £1bn (€1.11bn; $1.25bn) or more needed to bring a new…
